Thursday, June 14, 2018 3:32:11 PM
Response/clearance for general use 6-10 weeks
Filing for post surgical use?
Dr Scholls/possible other deals post-muskuloskeletal clearance?
FDA Innovation Challenge-November 2018
Update on path forward for allay?
Good stuff above. I guess i should have put quarterly earnings in there too. I didn't expect a lot from B Braun for this Q and after Uncle Andy saying how slow it was going there won't be an upside surprise from them. Maybe we will see an uptick in sales from the build up of inventory for the UK.
We may also get some details on the Sweden situation. Having a second country's health service start using Actipatch will be further confirmation that it can reduce healthcare costs. BIEL has part of the solution for two major political hot button issues, healthcare costs and opioid addiction. That's why if we get chosen in the FDA Innovation Challenge, it will be a big deal.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM